AU5998399A - Composition for treatment of light-injured retinal degeneration disease - Google Patents

Composition for treatment of light-injured retinal degeneration disease Download PDF

Info

Publication number
AU5998399A
AU5998399A AU59983/99A AU5998399A AU5998399A AU 5998399 A AU5998399 A AU 5998399A AU 59983/99 A AU59983/99 A AU 59983/99A AU 5998399 A AU5998399 A AU 5998399A AU 5998399 A AU5998399 A AU 5998399A
Authority
AU
Australia
Prior art keywords
light
treatment
lower alkyl
retinal degeneration
degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59983/99A
Other languages
English (en)
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Publication of AU5998399A publication Critical patent/AU5998399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU59983/99A 1998-10-02 1999-09-29 Composition for treatment of light-injured retinal degeneration disease Abandoned AU5998399A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10297298P 1998-10-02 1998-10-02
US60102972 1998-10-02
US11070098P 1998-12-03 1998-12-03
US60110700 1998-12-03
PCT/JP1999/005321 WO2000020002A1 (en) 1998-10-02 1999-09-29 Composition for treatment of light-injured retinal degeneration disease

Publications (1)

Publication Number Publication Date
AU5998399A true AU5998399A (en) 2000-04-26

Family

ID=26799937

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59983/99A Abandoned AU5998399A (en) 1998-10-02 1999-09-29 Composition for treatment of light-injured retinal degeneration disease

Country Status (8)

Country Link
US (1) US6248759B1 (https=)
EP (1) EP1117404A1 (https=)
JP (1) JP2002526409A (https=)
AR (1) AR020681A1 (https=)
AU (1) AU5998399A (https=)
BR (1) BR9914254A (https=)
CA (1) CA2346086A1 (https=)
WO (1) WO2000020002A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005204391A1 (en) * 2004-01-14 2005-07-28 Lavipharm Laboratories, Inc. Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
WO1990006123A1 (en) * 1988-12-05 1990-06-14 Houston Biotechnology Incorporated Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
FR2642307A1 (fr) * 1989-01-27 1990-08-03 Corbiere Jerome Medicament pour le traitement des maladies degeneratives de la retine et notamment des maladies conditionnees genetiquement, et un procede pour leur obtention
JP3041923B2 (ja) * 1990-06-27 2000-05-15 藤沢薬品工業株式会社 ジヒドロピリジン化合物を含有する抗炎症および活性酸素産生抑制剤
US5691360A (en) * 1993-12-08 1997-11-25 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
EP0911027A4 (en) 1996-04-26 2000-11-29 Fujisawa Pharmaceutical Co THE DIHYDROPYRIDINE CONTAINS TO IMPROVE THE CIRCULATION OF THE EYE-SURROUNDING TISSUE
JPH1072347A (ja) 1996-05-27 1998-03-17 Otsuka Pharmaceut Co Ltd 眼血管血流改善剤

Also Published As

Publication number Publication date
WO2000020002A1 (en) 2000-04-13
JP2002526409A (ja) 2002-08-20
BR9914254A (pt) 2001-07-03
EP1117404A1 (en) 2001-07-25
CA2346086A1 (en) 2000-04-13
AR020681A1 (es) 2002-05-22
US6248759B1 (en) 2001-06-19

Similar Documents

Publication Publication Date Title
US5863948A (en) Increasing aqueous humor outflow
US4599353A (en) Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP2156833B1 (en) Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
AU2017326791A1 (en) Medicinal composition
CN114845718B (zh) 用于治疗与过度血管形成相关的眼部疾病的化合物
TW202446398A (zh) 具眼壓下降作用之醫藥
JP7801201B2 (ja) ヘテロシクリデンアセトアミド誘導体含有医薬
RU2414904C2 (ru) ЗАЩИТНОЕ СРЕДСТВО ДЛЯ НЕЙРОНА СЕТЧАТКИ, СОДЕРЖАЩЕЕ В КАЧЕСТВЕ АКТИВНОГО КОМПОНЕНТА ПРОИЗВОДНОЕ ПРОСТАГЛАНДИНА F2α
JP2018024677A (ja) ラキニモドを使用する眼炎症性疾患の治療
BR112019020430A2 (pt) Métodos e composições para tratar doença associada à retina usando inibidores de ccr3
US11717513B2 (en) Mirabegron for the treatment of retinal diseases
CN115768433A (zh) 含有司培前列素的医药制剂
US6248759B1 (en) Method for treatment of light-injured retinal degeneration disease
JP2000507205A (ja) 眼の虚血障害の治療薬の製造のためのポリアミン部位拮抗物質の使用
KR980008226A (ko) 시각기능장애의 예방 및 치료제
EP0647445B1 (en) Composition for prophylaxis and treatment of myopia
CZ324094A3 (en) NOVEL APPLICATION OF BENZO/g/QUINOLINES
CA2528148A1 (en) Coumarin derivatives for the treatment of ophthalmic disorders
JP3066561B2 (ja) 近視予防・治療剤
AU2834901A (en) Rivastigmine for the treatment of ocular disorders
JP2001519394A (ja) 緑内障の局所治療用フルナリジンの使用法
JPWO2005079792A1 (ja) 重症糖尿病網膜症の予防又は治療剤
WO2010010939A1 (ja) 加齢黄斑変性の予防又は治療剤
KR100854058B1 (ko) 스테로이드를 유효 성분으로 하는 망맥락막 질환 치료제
JP2004262812A (ja) 眼圧低下剤

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted